EUVIMEDEUVIMED entdecken
Open Access

Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice

Narges Mardi iD, Amir Zarebkohan, Cigir Biray-Avci, Reza Rahbarghazi, Mehdi Talebi, Hamid Lotfimehr, Sharareh Khavandkari, Zahra Abbasi-Malati, Nastaran Sedghi-Samarkhazan, Elham Shahriyari, Asghar Khalilnezhad, Morteza Milani iD und 1 weitere

BioImpacts · 15.06.2026 · 16 · 33180

DOI: 10.34172/bi.33180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 15.06.2026. Verfasst von Narges Mardi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Triple-negative breast cancer demonstrated high metastasis and mortality rates in female populations. Emerging data on effective targeting and specific internalization of chemotherapeutic agents, using modified exosomes, decreased the therapeutic dosage of anti-cancer drugs in cancer cells.

Methods

Herein, we developed modified exosomes by surface decoration using the Fusion protein of Respiratory Syncytial Virus (F-protein of RSV) through Click-chemistry techniques, and Dox-loaded via sonication strategy. Then, the viability and metastatic behaviors of MDA-MB-231 cells were monitored in the presence of different groups, including Dox, Exosomes (Exo), Exosomes loaded with Dox (Exo@Dox), and F-protein coupled Exosome groups (Exo-F) and (Exo-F@Dox).

Results

In vitro and in vivo results verified that the F-protein coupled exosome, as a modified natural nanoplatform, possessed a biocompatible nature in blood circulation and crossing of blood barriers. After exposure to tumoral temperature (40 °C) and lysosomal PH (5.5) demonstrate amplified Dox release (around 60% at 8 h). Also, in vitro uptake results confirmed a significant increase in Exo-F internalization compared to the Exo group in MDA-MB-231 cells (P

Schlagwörter

Stichwörter der Autor:innen

Breast cancerFusion protein of RSVModified exosomesTargeted delivery

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Narges Mardi, Morteza Milani, Mohammad Nouri

Zitieren

APA

Mardi, N., Zarebkohan, A., Biray-Avci, C., Rahbarghazi, R., Talebi, M., Lotfimehr, H., Khavandkari, S., Abbasi-Malati, Z., Sedghi-Samarkhazan, N., Shahriyari, E., Khalilnezhad, A., Milani, M., & Nouri, M. (2026). Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice. BioImpacts, 16, 33180. https://doi.org/10.34172/bi.33180

Vancouver

Mardi N, Zarebkohan A, Biray-Avci C, Rahbarghazi R, Talebi M, Lotfimehr H, et al. Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice. BioImpacts. 2026;16:33180. doi:10.34172/bi.33180

BibTeX
@article{Mardi2026,
  author = {Mardi, Narges and Zarebkohan, Amir and Biray-Avci, Cigir and Rahbarghazi, Reza and Talebi, Mehdi and Lotfimehr, Hamid and Khavandkari, Sharareh and Abbasi-Malati, Zahra and Sedghi-Samarkhazan, Nastaran and Shahriyari, Elham and Khalilnezhad, Asghar and Milani, Morteza and Nouri, Mohammad},
  title = {Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice},
  journal = {BioImpacts},
  year = {2026},
  volume = {16},
  pages = {33180},
  doi = {10.34172/bi.33180}
}
Kostenlos starten →